Skip to main content
Saudi Journal of Biological Sciences logoLink to Saudi Journal of Biological Sciences
. 2021 Jul 24;28(12):6782–6794. doi: 10.1016/j.sjbs.2021.07.059

Selenium nanoparticles from Lactobacillus paracasei HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk

Mohamed T El-Saadony a, Ahmed M Saad b, Taha F Taha b, Azhar A Najjar c, Nidal M Zabermawi c, Maha M Nader a, Synan F AbuQamar d,, Khaled A El-Tarabily d,e,, Ali Salama a
PMCID: PMC8626219  PMID: 34866977

Graphical abstract

graphic file with name ga1.jpg

Keyword: Animals' pathogenic fungi, Antifungal metabolites, Biosynthesis, Lactobacillus paracasei, Selenium nanoparticles

Abstract

The current study was performed to develop a simple, safe, and cost-effective technique for the biosynthesis of selenium nanoparticles (SeNPs) from lactic acid bacteria (LAB) isolated from human breast milk with antifungal activity against animal pathogenic fungi. The LAB was selected based on their speed of transforming sodium selenite (Na2SeO3) to SeNPs. Out of the four identified LAB isolates, only one strain produced dark red color within 32 h of incubation, indicating that this isolate was the fastest in transforming Na2SeO3 to SeNPs; and was chosen for the biosynthesis of LAB-SeNPs. The superior isolate was further identified as Lactobacillus paracasei HM1 (MW390875) based on matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and phylogenetic tree analysis of 16S rRNA sequence alignments. The optimum experimental conditions for the biosynthesis of SeNPs by L. paracasei HM1 were found to be pH (6.0), temperature (35˚C), Na2SeO3 (4.0 mM), reaction time (32 h), and agitation speed (160 rpm). The ultraviolet absorbance of L. paracasei-SeNPs was detected at 300 nm, and the transmission electron microscopy (TEM) captured a diameter range between 3.0 and 50.0 nm. The energy-dispersive X-ray spectroscopy (EDX) and the Fourier-transform infrared spectroscopy (FTIR) provided a clear image of the active groups associated with the stability of L. paracasei-SeNPs. The size of L. paracasei-SeNPs using dynamic light scattering technique was 56.91 ± 1.8 nm, and zeta potential value was −20.1 ± 0.6 mV in one peak. The data also revealed that L. paracasei-SeNPs effectively inhibited the growth of Candida and Fusarium species, and this was further confirmed by scanning electron microscopy (SEM). The current study concluded that the SeNPs obtained from L. paracasei HM1 could be used to prepare biological antifungal formulations effective against major animal pathogenic fungi. The antifungal activity of the biologically synthesized SeNPs using L. paracasei HM1 outperforms the chemically produced SeNPs. In vivo studies showing the antagonistic effect of SeNPs on pathogenic fungi are underway to demonstrate the potential of a therapeutic agent to treat animals against major infectious fungal diseases.

1. Introduction

Fungi are an extremely versatile class of organisms which can attack different hosts, causing many serious diseases (Seyedmousavi et al., 2018). The importance of fungal infections in humans and animals has increased over the last two decades (Dworecka-Kaszak et al., 2020). These diseases caused by fungi can be difficult to treat due to developing resistance to standard antifungal drugs (Fisher et al., 2012, Yapar, 2014).

The filamentous fungus Fusarium and the yeast Candida infects animals and causes several diseases. The genus Candida includes>200 species, of which 15 have been identified as the causal agents of many human and animal diseases (Yapar, 2014). The most prominent of these pathogens are Candida albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropicalis. Diseases associated with C. albicans and C. glabrata often occur in warm-blooded hosts (Yapar, 2014). Candida infection usually occurs by the colonization of the host rather than the longitudinal and vertical transmission (Yapar, 2014).

Fusarium is one of the emerging causes of opportunistic mycoses, with approximately 15 species reported to cause human and animal diseases (Jain et al., 2011), including Fusarium solani (the most common), F. anthophilum, F. oxysporum, F. proliferatum and F. verticoides. These Fusarium species produce mycotoxins such as trichothecenes mainly nivalenol, deoxynivalenol (DON), T-2 and HT-2 toxins, zearalenone (ZEN), and fumonisins (B1, B2, and B3) (Antonissen et al., 2014).

As a global problem, mycotoxins are toxic fungal metabolites that can contaminate a wide array of food and feed (Al‐Maqtoofi and Thornton, 2016). Fusarium mycotoxins are capable of inducing acute and chronic toxic effects and can be life-threatening. The toxic effects mainly depend on the type of mycotoxins, the level and duration of exposure, the animal species, and the age of the animal exposed (Al‐Maqtoofi and Thornton, 2016). Intake of high doses of mycotoxin may lead to acute mycotoxicoses characterized by well-described clinical symptoms (Smith et al., 2005, Antonissen et al., 2014). Exposure of pigs to high concentrations of DON causes abdominal distress, malaise, diarrhea, emesis, and even shock or death. Fumonisins lead to pulmonary edema in pigs due to cardiac insufficiency, cause equine leukoencephalomalacia (ELEM), and target the brains of horses (Devreese et al., 2013).

Some secondary metabolites and nanoparticles (NPs) can be biosynthesized from microorganisms. Generally, NPs can play an important role in eliminating environmental stresses and microbial infections and can enhance growth and performance in farm animals (Alagawany et al., 2021a, Abdelnour et al., 2020a, Reda et al., 2020, Sheiha et al., 2020, Alagawany et al., 2021b). Turner and Butler (2014) demonstrated the critical role of NPs in treating invasive fungal infections, especially those caused by yeast fungi such as Candida species. The NPs showed unique characteristics due to their tremendously small size and high surface area to the volume ratio (Singh et al., 2011).

Selenium (Se) is an essential trace element present in humans, animals, and some microorganisms; and is considered a vital cofactor of anti-oxidant enzymes such as thioredoxin reductase and glutathione peroxidase (Husen and Siddiqi, 2014, Srivastava and Mukhopadhyay, 2015). The SeNPs have potential for use in nanomedicines for their antimicrobial and anticancer properties (Forootanfar et al., 2014, Wadhwani et al., 2016). By using the recent approaches of nanotechnology, the biological synthesis of SeNPs with high efficiency, low-cost and accurate productivity has replaced the traditional physical and chemical procedures (Wadhwani et al., 2016). Biosynthesis of NPs involves the use of uni- and multi-cellular microorganisms including bacteria and fungi (El-Saadony et al., 2018; El-Saadony et al., 2021a; El-Saadony et al., 2021b; El-Saadony et al., 2021c; El-Saadony et al., 2021d; Reda et al., 2021), yeasts (Moghaddam et al., 2017, Shamsuzzaman et al., 2017), algae (Azizi et al., 2014), and some nonliving viral particles (Nam et al., 2006).

There have been investigations for an economical and straightforward biological method for the biotransformation of SeNPs using lactic acid bacteria (LAB) (Radhika and Gayathri, 2015). Thus, the use of whole bacterial cells or bacterial enzymes is an excellent substitute for the large-scale commercial biotransformation of SeNPs. The toxic form of selenium in selenite can be converted into non-toxic Se (insoluble in water) by microorganisms (Radhika and Gayathri, 2015).

Long-term water or plant consumption from Se–rich soil may lead to skin injury and early hair loss. Consequently, efforts have been made to convert toxic Se compounds to beneficial non-toxic Se using bacteria (Bajaj et al., 2012). Microorganisms such as Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus helveticus, Lactobacillus rhamnosus, Lactobacillus plantarum, Klebsiella pneumoniae, Streptococcus thermophilus, and Bifidobacterium can act as small nano-factories secreting enzymes converting metal ions to metal NPs (Sasidharan and Balakrishnaraja, 2014, Radhika and Gayathri, 2015, Alam et al., 2020).

Due to the limitless microorganisms that can biosynthesize Se, researchers have focused on detecting novel effective isolates. In medicine, SeNPs have been reported to show low toxicity and high biological activity (Hartikainen et al., 2000, Wang et al., 2007). In addition, many studies have shown that some organic forms of Se have anticarcinogenic characteristics (Tapiero et al., 2003).

Candida and Fusarium infections are difficult to cure and can be lethal to animals, so novel antimicrobial formulations are needed. Accordingly, the current work aimed to (i) synthesize SeNPs using LAB, (ii) study the optimum culture conditions required for the production of these biogenic SeNPs, and (iii) examine the potential of these LAB-SeNPs as antifungal agents against pathogenic fungi in animals.

2. Materials and methods

2.1. Collection of human breast milk samples

Breast milk samples were obtained from three healthy breastfeeding volunteers. Milk samples were aseptically collected in sterile containers using clean gloves. Nipples were first washed with soap and sterile water, and the first milk drops (~500 μl) were discarded. The collected samples were stored at 4 °C until transporting to the laboratories of the Agricultural Microbiology Department, Faculty of Agriculture, Zagazig University, Egypt, for immediate processing.

2.2. Isolation of LAB from human breast milk

A ten-fold dilution of each milk sample was prepared in 0.9% sterile saline solution. Each dilution (0.1 ml each) was spread across the surface of selective agar media in sterilized plastic petri dishes (90 mm diameter) using sterilized L-shaped spreaders. For each dilution, three plates were used for each sample.

For the isolation of Lactobacillus species, de Man Rogosa and Sharpe (MRS) agar medium (CM0361, Oxoid Ltd., Basingstoke, Hampshire, UK) at pH 6.5 was used. However, for the isolation of bifidobacteria, MRS agar amended with cysteine (Sigma–Aldrich Chemie GmbH, Taufkirchen, Germany) at pH 5.2 was used (Argyri et al., 2013).

The cultures were incubated using AnaeroGen sacks (Oxoid Ltd.) at 37 ± 2 °C in an anaerobic GasPak system (Becton Dickinson, NJ, USA) for 48 h. Colonies were randomly collected from each sample and purified using streak plate technique on MRS agar medium. All bacterial cultures were kept at a temperature of 4 °C until use.

2.3. Production of LAB-SeNPs

Luria-Bertani (LB) broth was prepared by dissolving 10 g tryptone, 5 g yeast extract, and 5 g sodium chloride in 1000 ml distilled water (pH 7.5). The enrichment medium used in the current study was prepared by dissolving 0.5 g sodium nitrate, 5 g sodium chloride, 0.1 g ammonium chloride, 2.7 g di-potassium hydrogen phosphate, 3 g tryptone, 1 g beef extract, 0.5 g yeast extract, and 3 g glucose in 1000 ml distilled water. LB medium and enrichment medium were as described by Radhika and Gayathri (2015). Freshly cultivated LAB isolates were inoculated into 100 ml LB broth and placed in a shaking incubator at 170 rpm until reaching log phase (~12 h) at 35 °C according to Radhika and Gayathri (2015) with some modifications. The supernatant was discarded after centrifugation at 6,000 × g for 10 min. The bacterial pellet for each LAB was homogenized in 100 ml of the enrichment medium supplemented with 4.0 mM of Na2SeO3 (Sigma–Aldrich) as described by Radhika and Gayathri (2015). The flasks were incubated in a shaking incubator at 170 rpm at 35 °C for 40 h. After incubation, the formed SeNPs were harvested by centrifugation at 8,000 × g for 10 min, and washed four times with distilled water. The LAB-SeNPs were further analyzed using multiple characterization techniques (Boroumand et al., 2019).

The LAB selection for further experiments was based on their ability to change the bright yellow medium to red color after a 32 h incubation. The presence of red color in the medium containing Na2SeO3 and the tested bacterium approves the transformation of Na2SeO3 to SeNPs by the LAB isolate. Only four LAB isolates were able to transform Na2SeO3 to red SeNPs. The superior LAB isolate (HM1) possessing the highest production of stable SeNPs was chosen for the biosynthesis of LAB-SeNPs for all the experiments described below. This isolate was the fastest to transform Na2SeO3 to SeNPs, and produced a dark red color by 32 h compared to the other three LAB isolates, which produced pale red color after 40 h of incubation.

2.4. Identification of the superior LAB isolate HM1

The selected isolate (HM1) was putatively identified according to its morphological, biochemical, and physiological characteristics as recommended by Bergey′s Manual of Systematic Bacteriology (Logan and De vos, 2009). The tests included cell morphology, Gram reaction, production of catalase enzyme and ammonia (NH3), the ability to grow at 15 °C (5 days) and 45 °C (2 days) in MRS broth, and salt tolerance (4%, and 6.5% NaCl in MRS). Sugar fermentation tests were also carried out using trehalose, lactose, raffinose, sucrose, cellobiose, galactose, xylose, mannitol, melezitose, melibiose, ribose, sorbitol, and arabinose (Logan and De vos, 2009).

The identification of isolate HM1 was confirmed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (Nacef et al., 2017) in addition to the phylogenetic analysis using 16S rRNA gene alignment sequences.

DNA of the LAB isolate HM1 was extracted and purified (Sambrook et al., 1989). The amplification procedures were followed using PCR (Veriti 96 well thermal cycler, Applied Biosystems®, San Francisco, CA, USA) and the QIA quick PCR purification kit (Baek et al., 2010). The 16S rRNA gene was amplified using the set 27 forward primer (5′AGAGTTT GATCMTGGCTCAG-3′) and 1492 reverse primer (5′-TACGGYTACCTTGTTACG ACTT-3′), according to Srivastava et al. (2008). The gene was sequenced using a 3500 Genetic Analyzer (Applied Biosystems®), using a peak block ramp rate of 3.9 °C⁄sec, reaction volume range of 10–100 µl, sample ramp rate of ± 3.35 °C⁄sec, and a temperature range (metric): 4.0–99.9 °C.

The phylogenetic tree was constructed using the neighbor-joining method (Saitou and Nei, 1987). Trees replicate (%) which associated with taxa clustered was calculated with the bootstrap test (100 replicates) (Felsenstein, 1985). The evolutionary distances were computed using the maximum composite as Tamura et al. (2004) method and are in the units of the number of base substitutions per site. Evolutionary analyses were conducted using Molecular Evolutionary Genetics Analysis Version X (MEGAX) software (Kumar et al., 2016).

2.5. Optimization of culture conditions to improve the production of LAB-SeNPs

Several experiments were carried out to determine the optimum culture conditions required to improve the production of LAB-SeNPs. The freshly prepared bacterial inoculum grown on enrichment medium was supplemented with Na2SeO3 under various growth conditions described below. The conditions tested were; pH values (5.0, 6.0, 7.0, 8.0, 9.0, and 10.0), temperature (20, 25, 30, 35, 40, and 45 °C), and different concentrations of Na2SeO3 (1, 2, 3, 4, 5, and 6 mM). The flasks were incubated at different time intervals (1, 8, 16, 24, 32, and 40 h) and agitated at 100, 120, 140, 160, 180, and 200 rpm using a shaking incubator. Optical density (OD) was measured at 300 nm (OD300) using a scanning spectrophotometer (UV-2101/3101 PC; Shimadzu Corporation, Analytical Instruments Division, Kyoto, Japan). These experiments were carried out according to Ghorbani et al., 2011, Wadhwani et al., 2017; and El-Saadony et al. (2020a) with some modifications. In each of these experiments, all factors were kept constant except for one varied factor.

2.6. Separation and purification of LAB-SeNPs

The LAB-SeNPs were centrifuged at 8,000 × g for 10 min, and the pellet was re-suspended in sterile distilled water. The LAB-SeNPs were lyophilized by freeze-drying (Thermo Fisher Scientific, Waltham, MA, USA) at −60˚C for 24 h and kept at 4 °C until further use (Wadhwani et al., 2017). The stability of the LAB-SeNPs was confirmed after ten weeks of cold storage by the absence of precipitates.

2.7. Characterization of LAB-SeNPs

After observing LAB-SeNPs formation by the media changing color from yellow to dark red, they were further characterized by ultraviolet (UV)–visible spectroscopy. The prepared mixture was monitored using Laxco™ dual-beam spectrophotometer, alpha series, 200–1000 nm (Mettler-Toledo LLC., Columbus, OH, USA) (Forough and Farhadi, 2010) to detect the surface plasmon resonance (SPR) of the obtained absorbance peak for LAB-SeNPs.

Fourier-transform infrared spectroscopy (FTIR; Bruker Tensor, Kaller, Germany) analysis was performed (Chattopadhyay et al., 2013) to determine the interaction between proteins found in cell-free extract and LAB-SeNPs. The FTIR was also used to identify the potential active compounds in the bacterial cell-free extract.

The LAB-SeNPs were also exposed to energy-dispersive X-ray spectroscopy (EDX) using JEOL (JSM–IT200 Series, Peabody, MA, USA) in order the determine the elemental composition of LAB-SeNPs. The shape and size of LAB-SeNPs were measured using transmission electron microscopy (TEM; JEOL Ltd., Tokyo, Japan) (Mendez et al., 2011).

Dynamic light scattering (DLS) (Malvern Panalytical, Malvern, UK) measured the particle size of nanoparticles in dispersals and aggregation rate (Gunti et al., 2019). The polydispersity index (PDI) measures the NPs’ homogeneous nature; the smaller the PDI, the more homogeneous NPs (Gunti et al., 2019).

The size distribution of LAB-SeNPs was monitored at 27 ± 2 °C using a Zetasizer nano range (Malvern Panalytical, Malvern, UK). The Zeta potential of the NPs was measured to determine its surface charge using a zeta-potential instrument (Malvern Panalytical, Malvern, UK) (Gunti et al., 2019).

The nature of LAB-SeNPs was further analyzed using X-ray diffraction (XRD). The LAB-SeNPs cast was collected on a glass slide and observed under D8 Advance Brucker X-ray diffractometer with Cu Kα (1.54°A) (Brucker Corporation, Billerica, MA, USA) as described by Ganachari et al. (2012).

2.8. Preparation of chemically produced SeNPs (Che-SeNPs)

The SeNPs were fabricated using the wet chemical method (Shar et al., 2019). Briefly, 4 g of ascorbic acid was mixed in 20 ml sterilized deionized water on a magnetic stirrer for 10 min at 30˚C. A 0.01 mol solution of Na2SeO3 was dissolved in 200 ml sterilized deionized water and mixed at 90 °C for 1 h. Drops of ascorbic acid solution were slowly added to the Na2SeO3 solution for 10 min. The colorless Na2SeO3 gradually changed from yellow to red color, indicating that the Che-SeNPs were successfully fabricated. The mixture was then centrifuged at 7,500 × g for 10 min, and the pellet was removed by rinsing five times with sterilized deionized water. The che-SeNPs obtained were overnight vacuum-dried at 60 °C, and stored at 4 °C. All other factors were kept constant to reach the optimum conditions.

2.9. Determination of the antifungal activity of LAB-SeNPs

The antifungal activities of the LAB-SeNPs and Che-SeNPs were tested against the following fungal species: Candida albicans ATCC 4862, C. glabrata ATCC 64677, C. krusei ATCC 14243, C. parapsilosis ATCC 22019, C. tropicalis ATCC 66029, Fusarium oxysporum ATCC 62506, and F. solani ATCC 38341. The tested Candida and fungi were cultivated on Sabouraud’s dextrose agar plates (SDA) (Lab M Ltd., Heywood, Lancashire, UK) and the plates were incubated at optimum condition for Candida and Fusarium (37 °C for 2 days and 30 °C for 5 days), respectively (Balouiri et al., 2016). The antifungal activities of LAB-SeNPs and che-SeNPs (15, 30, 45, 60, and 75 µg ml−1) against these fungal species were evaluated using the agar disc diffusion assay (Hariharan et al., 2012). The tested Candida spp., were grown on SDB at 37˚C until concentration of approximately 105 CFU ml−1. Fusarium spp., were grown on Sabouraud dextrose agar (SDA) medium for 5 days at 30˚C, and 6 mm mycelial discs were obtained (Saeed et al., 2017). Candida spp., inoculum (100 µl) was spread over SDA plates, and Fusarium mycelial discs were added in the center of SDA plates. The antifungal activity of LAB-SeNPs and Che-SeNPs levels (15, 30, 45, 60, and 75 µg ml−1) was evaluated using the agar disc diffusion assay method (Hariharan et al., 2012). Discs (6 mm diam.) were saturated with each concentration of LAB-SeNPs, Che-SeNPs, and sodium selenite (Na2SeO3; control) then was put on the sides of seeded SDA plates, the plates were incubated at optimum condition for Candida and Fusarium (37 °C for 2 days and 30 °C for 5 days), respectively. The antifungal activity was estimated by measuring the inhibition zones diameters (mm). Three plates were used for each fungal isolate. The interaction between LAB-SeNPs and the Fusarium species was also observed by scanning electron microscopy (SEM) (JEOL, Ltd., Tokyo, Japan) (Bozzola and Russell, 1999).

2.10. Determination of the minimum inhibitory concentration and minimum fungicidal concentration of Che-SeNPs and LAB-SeNPs

The minimum inhibitory concentration (MIC) of Che-SeNPs and LAB-SeNPs was estimated by micro broth dilution method (Saeed et al., 2017, Ashour et al., 2020). Aliquots of 500 µl for each Che-SeNPs and LAB-SeNP concentration (15, 30, 45, 60, and 75 µg ml−1) were added to tubes containing Sabouraud dextrose broth (SDB) (Lab M) inoculated with 500 µl of Candida or Fusarium inoculum (~105 CFU ml−1). Tubes were incubated at optimum conditions for Candida and Fusarium (37 °C for 2 days and 30 °C for 5 days), respectively. The obtained turbidity was measured at 600 nm using a spectrophotometer (Shimadzu Corporation). The lowest concentration of Che-SeNPs or LAB-SeNPs, which inhibited the fungal growth, was recorded as the MIC. In addition, the lowest concentration of Che-SeNPs or LAB-SeNPs which inhibited the fungal growth, was considered to be the minimum fungicidal concentration (MFC) (Abdelnour et al., 2020a, Ashour et al., 2020). The MFC was estimated by sub-culturing the MIC levels of Che-SeNPs or LAB-SeNPs onto sterile SDA plates. the plates were incubated at optimum condition for Candida and Fusarium (37 °C for 2 days and 30 °C for 5 days), respectively.

2.11. Statistical analysis

Probability analysis was performed (Finney, 1971). Parameters were analyzed using SPSS Version 20.0 for windows (SPSS Inc., Chicago, IL, USA). All tests were independently replicated three times. Data were subjected to analysis of variance (ANOVA), and Fisher’s protected least significant difference (LSD) test at P = 0.05 was applied to compare significant differences among means for all analyses.

3. Results

3.1. Isolation of LAB from human breast milk

In the current study, 15 different LAB isolates were obtained from human breast milk on MRS, and MRS agar amended with cysteine, under anaerobic conditions. Ten different isolates were tentatively selected based on their cultural and morphological features. The ten isolates were purified on MRS agar.

3.2. Screening of LAB-SeNPs

The first step in the screening process involved testing the ten selected LAB for their ability to convert the color of the medium from bright yellow to red color at the end of the incubation period. The red color in the medium containing Na2SeO3 and the tested bacterium confirms the transformation of Na2SeO3 to SeNPs by the LAB isolates (Fig. 1). Out of the ten LAB isolates tested, only four (HM1, HM5, HM6, and HM7) could transform Na2SeO3 to SeNPs, and produced red color. The remaining six LAB isolates failed to produce any red color and were excluded in the remaining experiments. Only isolate HM1 was selected for the biosynthesis of LAB-SeNPs as it was the fastest isolate in transforming Na2SeO3 to SeNPs, and therefore it produced a dark red color by 32 h (Fig. 1). The other three isolates took 48 h and only produced pale red color.

Fig. 1.

Fig. 1

|Production of selenium nanoparticles (SeNPs) by Lactobacillus paracasei HM1 (a) Lactobacillus paracasei HM1 in Luria-Bertani (LB) broth medium, (b) supernatant of L. paracasei HM1, (c) sodium selenite (Na2SeO3), (d) supernatant of L. paracasei HM1 with Na2SeO3 after 32 h of incubation at 35 °C, and (e) pellet of L. paracasei HM1 homogenized in enrichment medium supplemented with Na2SeO3 after 32 h of incubation at 35 °C. In (e), note the formation of dark red color in flask.

3.3. Identification of the superior LAB isolate HM1

The LAB Isolate HM1 was a Gram-positive, catalase-negative, and non-spore-forming bacterium. It did not produce NH3 from arginine or gas from glucose, suggesting that this isolate is homo-fermentative. Isolate HM1 successfully grew at 15 °C, but not at 45 °C, and was tolerant to NaCl concentrations of 4 and 6.5%. The morphological, biochemical, and physiological characteristics of LAB Isolate HM1 is presented in Table 1. The identification of the LAB isolate HM1 was further confirmed using MALDI-TOF MS.

Table 1.

Morphological and biochemical characteristics of the selected lactic acid bacterium (LAB) isolate HM1.

Characteristics LAB isolate HM1
Gram reaction +
Endospore formation
Production of catalase
Production of NH3 from arginine



Growth at
15C +
45C
4% NaCl +
6.5% NaCl +
Production of gas from glucose



Fermentation of
Glucose +
Lactose +
Mannitol +
Galactose +
Cellobiose +
Xylose +
Sucrose +
Ribose +
Sorbitol +
Melezitose +
Raffinose
Xylose
Melibiose
Arabinose
Trehalose

+, growth or positive reaction; -, no growth or negative reaction.

The 16S rRNA sequencing results (Fig. 2) matched the identification of the isolate using MALDI-TOF MS. The LAB isolate HM1 was highly similar to the 16S rRNA gene sequences of other L. paracasei showing a 98.5–100% sequence identity range. The 16S rRNA nucleotide sequence was deposited in GenBank with an accession number (MW390875) under L. paracasei strain HM1. In addition, a comparative phylogenetic tree was established to find the relationship between the identified strain and the existing Lactobacillus group based on the 16S rRNA gene sequences (Fig. 2). The phylogenic analysis revealed that the isolated strain HM1 belonged to the genus Lactobacillus and mainly to the phylogenetic clade of L. paracasei. The present data suggest that the LAB, L. paracasei HM1, is a promising bacterium for the production of SeNPs.

Fig. 2.

Fig. 2

Identification of Lactobacillus paracasei HM1 based on phylogenetic characteristics. Analysis of the phylogenetic tree of the 16S rRNA gene sequence of L. paracasei HM1 (MW 390875) with other Lactobacillus species.

3.4. Optimization of the synthesis of SeNPs by L. paracasei HM1

The effects of different pH values of the culture medium on the production of SeNPs by L. paracasei HM1 are represented in Table 2. There was greater absorbance of the formed SeNPs at pH 6.0 compared to the other pH values. Above pH 6.0, the absorbance of LAB-SeNPs was significantly (P < 0.05) decreased. When fresh bacterial inoculum of L. paracasei HM1 was mixed with Na2SeO3, the absorbance measurements increased with increasing temperature (20 to 35 °C), with a maximum value obtained at 35 °C (Table 2). We found that increasing the temperature above 35 °C significantly (P < 0.05) decreased the formation of L. paracasei-SeNPs and at further temperature increases led to the aggregation of NPs.

Table 2.

In vitro growth conditions affecting the reaction between Lactobacillus paracasei HM1 and sodium selenite (Na2SeO3).

pH values 5.0 6.0 7.0 8.0 9.0 10.0



1.23 ± 0.001b 1.93 ± 0.003a 1.11 ± 0.001b 0.93 ± 0.007bc 0.63 ± 0.005c 0.32 ± 0.001d
Temperature (oC) 20 25 30 35 40 45



0.93 ± 0.007c 1.12 ± 0.001c 1.75 ± 0.007b 2.12 ± 0.005a 1.89 ± 0.003ab 1.71 ± 0.009b
Na2SeO3 (mmol) 1 2 3 4 5 6



1.42 ± 0.001d 1.62 ± 0.003c 1.82 ± 0.001bc 2.14 ± 0.007a 1.92 ± 0.009b 1.61 ± 0.007c
Reaction time (h) 1 8 16 24 32 40



1.32 ± 0.003c 1.45 ± 0.001c 1.76 ± 0.007bc 1.89 ± 0.003b 2.12 ± 0.009a 2.11 ± 0.007a
Agitation speed (rpm) 100 120 140 160 180 200



1.34 ± 0.009c 1.46 ± 0.003c 1.53 ± 0.007bc 2.17 ± 0.001a 1.96 ± 0.005ab 1.89 ± 0.001b

Optical density (OD) measurements at 300 nm (OD300) were determined using spectrophotometer. Mean ± standard deviation (n = 3) of OD300. Values with the same letter within a row are not significantly (P > 0.05) different according to Fisher’s Protected LSD Test.

Biotransformation of SeNPs was detected at Na2SeO3 concentrations up to 6.0 mM (Table 2). The red color intensity was enhanced when Na2SeO3 concentration increased from 1.0 to 4.0 mM; indicating that 4.0 mM Na2SeO3 was considered to be optimal for the SeNPs synthesis (Table 2). It was also noted that concentrations of Na2SeO3 above 4.0 mM significantly (P < 0.05) decreased the formation of L. paracasei-SeNPs.

We also investigated the effect of incubation time (1, 8, 16, 24, 32, and 40 h) (Table 2). At incubations of<1 h, there was no production of SeNPs, which could be attributed to the reduction of Na2SeO3 redox potential. Moreover, there was an increase in the absorption peak as the reaction time increased (Table 2). Thus, more L. paracasei-SeNPs were produced by increasing the incubation period to 32 h, indicating that 32 h was the optimum incubation period to complete the reaction. It is noteworthy to mention that there was no significant (P > 0.05) difference between the 32 and 40 h incubation periods.

Another significant parameter that affects SeNPs output is the agitation level. We showed that SeNPs had an optimum production at 160 rpm during incubation compared to the other speeds (Table 2). Increasing the agitation speed from 100 to 160 rpm provided a more homogeneous environment, increasing the reaction’s surface area. However, above 160 rpm there was significantly (P < 0.05) less formation of L. paracasei-SeNPs (Table 2).

In conclusion, the optimum cultivation conditions for L. paracasei-SeNPs were pH 6.0, 35˚C, 4.0 mM Na2SeO3, 32 h reaction time, and 160 rpm agitation speed (Table 2).

3.5. Characterization of L. paracasei-SeNPs

3.5.1. Visualization of L. paracasei-SeNPs color

The reaction between Na2SeO3 and fresh inoculum of L. paracasei HM1 occurred rapidly and steadily in the enrichment media at 35 °C. The solution changed from light yellow to reddish-yellow after 2 h of incubation, gradually becoming dark red by 32 h, without further color change after that (Fig. 1). In the current study, SeNPs were formed inside the cells when L. paracasei HM1 pellets were added to enrichment medium supplemented with Na2SeO3. However, there was no change in the color when L. paracasei HM1 supernatant was added to Na2SeO3 (Fig. 1).

When UV–visible spectroscopy was used, the absorption peak for LAB-SeNPs was observed in the range of 200–1000 nm, and the absorbance of 300 nm was the peak for L. paracasei HM1 (Fig. 3A).

Fig. 3.

Fig. 3

Features of selenium nanoparticles (SeNPs) produced by Lactobacillus paracasei HM1. (a) Ultraviolet–visible spectroscopy spectrum of fabricated L. paracasei-SeNPs; and (b) transmission electron microscopy (80,000X) of SeNPs produced by L. paracasei HM1. In (a), note the formation of dark red color in the flask.

3.5.2. Determination of the shape and size of L. paracasei-SeNPs using TEM

Using TEM, the bio-fabrication of L. paracasei HM1 and the NPs size distribution were observed (Fig. 3B). The SeNPs size attained by the culture of L. paracasei HM1, under optimum conditions of 4.0 mM Na2SeO3 at pH 6.0 under 35 °C incubation for 32 h ranged between 3 and 50 nm in diameter. The TEM micrographs of the prepared L. paracasei-SeNPs showed that the L. paracasei-SeNPs were hexagonal monodispersed NPs (Fig. 3B). The L. paracasei-SeNPs did not aggregate, indicating the stabilization by the capping protein/peptide.

3.5.3. FTIR analysis

FTIR spectrum of L. paracasei-SeNPs showed nine distinct peaks at 3430.07, 2425.73, 1643.40, 1410.24, 1081.65, 988.34, 828.53, 608.68 and 542.80 cm−1 (Fig. 4). The current data indicated a strong, broad peak at 3430.07 cm−1, corresponding to the presence of primary and secondary amines and amide linkages in the protein and alcohols/phenols, respectively. The peak of 2425.73 cm−1 indicated the functional groups of aromatics and alkynes. The bands appearing at 1643.40 and 1410.24 cm−1 were assigned for alkenes and aromatics, respectively (Fig. 4). The peak at 1081.65 cm−1 proved the presence of phenol and alcoholic compounds. The peaks at 608.68, 988.34, and 828.53 cm−1 were due to the aromatic C–H bending. The peak at 542.80 cm−1 related to metal–carbon stretch (Fig. 4).

Fig. 4.

Fig. 4

Structural characteristics of selenium nanoparticles (SeNPs) produced by Lactobacillus paracasei HM1 using Fourier-transform infrared spectroscopy.

3.5.4. XRD analysis

The XRD analysis was used to investigate the structural characteristics of the formed L. paracasei-SeNPs. The XRD patterns of the L. paracasei-SeNPs were analyzed to determine the peak intensity, width, and position (Fig. 5). The obtained results indicated that the structure of the L. paracasei-SeNPs was spherical, crystalline, and all had a similar diffraction profile. The XRD spectrum of LAB-SeNPs showed eight peaks at Braggs angles, confirming the Se phase (Fig. 5). These XRD peaks at 2θ of 28.61°, 31.19°, 40.01°, 45.02°, 56.21°, 66.23°, 75.11°, and 84.74° could return it to the 100, 101, 110, 102, 111, 201, 112 and 202 crystallographic planes of the spherical shape of Se crystals. Thus, the current results suggest that the biosynthesized SeNPs were well-crystallized.

Fig. 5.

Fig. 5

Structural characteristics of selenium nanoparticles (SeNPs) produced by Lactobacillus paracasei HM1 using X-ray diffraction.

3.5.5. EDX analysis

We assessed the EDX analysis of LAB-SeNPs. The Se peak was at 1.4 keV (Fig. 6), which indicates that the bio-SeNPs were pure Se.

Fig. 6.

Fig. 6

Structural characteristics of selenium nanoparticles (SeNPs) produced by Lactobacillus paracasei HM1 using energy-dispersive X-ray spectroscopy.

3.5.6. DLS analysis

The DLS analysis measured the size distribution and polydispersity index (PDI) of L. paracasei-SeNPs. The average size of L. paracasei-SeNPs were 56.91 ± 1.8 nm (Fig. 7A), and the biotransformed L. paracasei-SeNPs were found to be monodispersed.

Fig. 7.

Fig. 7

Size and charge characterization of selenium nanoparticles (SeNPs) produced by Lactobacillus paracasei HM1. (a) Dynamic light scattering analysis of SeNPs showing size distribution of particles; and (b) zeta potential analysis showing the charge distribution on the SeNPs generated by L. paracasei HM1.

Zeta potential observed the surface charges gained by L. paracasei-SeNPs, which was responsible for the stability of the colloidal L. paracasei-SeNPs. Potential colloidal stability was predicted by the magnitude of zeta potential. L. paracasei-SeNPs zeta potential was found to be 20.1 ± 0.6 mV (Fig. 7B).

3.6. Determination of the antifungal activity of L. paracasei-SeNPs

The antifungal activity of Che-SeNPs and L. paracasei-SeNPs, in the present study, was evaluated against Candida spp., (C. albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropicalis) and Fusarium spp., (F. oxysporum and F. solani) using the disc diffusion method. In vitro results showed the effective antifungal activity of Che-SeNPs and L. paracasei-SeNPs against the five Candida and two Fusarium spp. (Table 3).

Table 3.

Antifungal activity demonstrated by inhibition zone (mm), minimum inhibitory concentration (μg ml−1) and minimum fungicidal concentration (μg ml−1) caused by the chemically produced selenium nanoparticles (Che-SeNPs) compared to selenium nanoparticles synthesized by Lactobacillus paracasei HM1 (LAB-SeNPs) at different concentrations against some pathogenic Candida and Fusarium species.

Fungal strains Che-SeNPs Concentration (μg ml−1)
LAB-SeNPs Concentration (μg ml−1)
Che
LAB
15 30 45 60 75 15 30 45 60 75 MIC MFC MIC MFC
C. albicans ATCC 4862 17 ± 0.2aD 19 ± 0.4aD 22 ± 0.3aC 25 ± 0.4aB 27 ± 0.2aAB 23 ± 0.2aC 25 ± 0.5aB 26 ± 0.2aB 27 ± 0.3aAB 29 ± 0.1aA 55d 95de 55bc 100c
C. parapsilosis ATCC 22019 16 ± 0.3abE 18 ± 0.3abD 20 ± 0.1bD 22 ± 0.1bC 25 ± 0.6abB 22 ± 0.4aC 24 ± 0.2aB 25 ± 0.4aB 26 ± 0.4abAB 27 ± 0.5abA 65bc 120d 60b 105c
C. krusei ATCC 14243 13 ± 0.5cE 17 ± 0.3bD 19 ± 0.4bC 21 ± 0.5bB 24 ± 0.6bAB 19 ± 0.6bC 20 ± 0.3bC 22 ± 0.2bB 24 ± 0.5bAB 25 ± 0.3bA 75b 135bc 70a 120b
C. glabrata ATCC 64677 12 ± 0.4cdF 15 ± 0.2cE 17 ± 0.4cC 20 ± 0.1bcB 22 ± 0.5cAB 17 ± 0.8bcC 18 ± 0.4bcC 20 ± 0.4bcB 22 ± 0.8cAB 23 ± 0.4bcA 85a 150a 65ab 110bc
C. tropicalis ATCC 66029 13 ± 0.3cE 16 ± 0.5bcD 18 ± 0.5bcC 21 ± 0.4bB 23 ± 0.4cAB 18 ± 0.7bC 19 ± 0.2bC 21 ± 0.5bcB 23 ± 0.5bcAB 24 ± 0.5bcA 80ab 140b 70a 130a
F. oxysporum ATCC 62506 14 ± 0.5cF 17 ± 0.4bE 19 ± 0.3bD 22 ± 0.3bC 24 ± 0.5bB 16 ± 0.8cE 19 ± 0.3bD 22 ± 0.6bC 24 ± 0.5bB 26 ± 0.2abA 70b 130c 50c 90d
F. solani ATCC 38341 16 ± 0.6abF 19 ± 0.2aE 21 ± 0.5aDE 23 ± 0.3abD 26 ± 0.8abC 18 ± 0.7bE 22 ± 0.2abD 25 ± 0.5aC 27 ± 0.4aB 29 ± 0.3aA 60c 100de 45c 80de

MIC, minimum inhibitory concentration; MFC, minimum fungicidal concentration. Values are means of 3 independent replicates for each experiment (means ± SD). Values with the same lower or upper case letter within a column or a row, respectively, are not significantly (P > 0.05) different according to Fisher's Protected LSD Test.

The results also showed that the in vitro antifungal activity of LAB-SeNPs was more effective than Che-SeNPs against the tested Candida and Fusarium spp. (Table 3). The interaction of LAB-SeNPs and Che-SeNPs with Candida spp., is presented in Table 3.

The data revealed that increasing the concentrations of L. paracasei-SeNPs, significantly (P < 0.05) increased the diameter of the inhibition zone when different species of Candida were tested (Table 3; Fig. 8). L. paracasei-SeNPs displayed more efficient and significant antifungal activity than the Che-SeNPs (Table 3). In general, all fungal strains were affected by the Che-SeNPs and LAB-SeNPs at all levels used (15, 30, 45, 60, and 75 µg ml−1) compared to 15 µg ml−1 Na2SeO3 (control) that gave an inhibition zone of<9 mm (Table 3; Fig. 8). All concentrations of LAB-SeNPs showed significant (P < 0.05) increased diameters of inhibition zones when compared to the Che-SeNPs (Table 3). Generally, the inhibition zones increased as L. paracasei-SeNPs levels increased (Table 3), while the maximum LAB-SeNPs concentration produced a maximum inhibition zone of 29 mm with F. solani and C. albicans (Table 3).

Fig. 8.

Fig. 8

Antifungal activity of selenium nanoparticles (SeNPs) synthesized by Lactobacillus paracasei HM1 on Candida species. (a) C. albicans ATCC 4862; (b) C. glabrata ATCC 64677; (c) C. tropicalis ATCC 66029; (d) C. parapsilosis ATCC 22019; and (e) C. krusei ATCC 14243. The concentration of SeNPs diffused into agar disc: (1) 15 μg chemically produced SeNPs/disc, (2) 15 μg L. paracasei-SeNPs/disc, (3) 30 μg L. paracasei-SeNPs/disc, (4) 45 μg L. paracasei-SeNPs/disc, (5) 60 μg L. paracasei-SeNPs/disc, and (6) 75 μg L. paracasei-SeNPs/disc.

Based on statistical analysis, all the antifungal activity of LAB-SeNPs levels significantly (P < 0.05) excelled the Che-SeNPs concentration with a relative increase of 20% against the animal pathogenic fungi species used in this study (Table 3).

In addition, SEM revealed that the L. paracasei-SeNPs severely damaged the Fusarium hyphae compared to the non-treated Fusarium (control) (Fig. 9).

Fig. 9.

Fig. 9

Scanning electron micrograph (500X) showing the interaction between Lactobacillus paracasei-selenium nanoparticles (SeNPs) and Fusarium oxysporum ATCC 62506. Healthy F. oxysporum mycelium without L. paracasei-SeNPs (control; left panel), and damaged F. oxysporum mycelium with 75 µg ml−1L. paracasei-SeNPs (right panel).

3.7. Determination of the MIC and MFC of Che-SeNPs and LAB-SeNPs

C. albicans, C. parapsilosis, and the two Fusaruim spp. were the most sensitive species to the antifungal activity of Che-SeNPs and LAB-SeNPs (15–75 µg ml−1) (Table 3). C. albicans, C. parapsilosis, F. oxysporum, and F. solani had MICs of 55, 60, 50, and 45 µg ml−1, respectively. The MICs of the remaining Candida spp., significantly (P < 0.05) increased by 15–20% over C. albicans, C. parapsilosis; and 30–40% over F. solani and F. oxysporum, respectively (Table 3). The LAB-SeNPs MFC was in the range of 80–130 µg ml−1, which ensured the complete killing of all tested fungi.

The same pattern was also found when Che-SeNPs were used. However, the MIC and MFC levels significantly (P < 0.05) increased by 15–20%. Simply, the MIC and MFC levels of Che-SeNPs were in the range between 55 and 85 µg ml−1 and 95–150 µg ml−1, respectively (Table 3).

4. Discussion

Fungal infection affects all living organisms in several ways, making them difficult to treat due to their resistance to common antifungal antibiotics and/or antifungal agents. Fusarium and Candida species infect animals as well as human; and in turn they cause several diseases. The aim of the current study was to create a green approach and low-cost technique for the biosynthesis of SeNPs using LAB to be used as antifungal agents. Biosynthesis of NPs involves the use of uni- and multi-cellular microorganisms (El-Saadony et al., 2021a, El-Saadony et al., 2021b, El-Saadony et al., 2021c, El-Saadony et al., 2021d).

In this respect, Olivares et al. (2006) have isolated four lactobacilli strains from human breast milk. They proposed that these lactobacilli strains could play an essential role in protecting neonates from various microbial infections and could be respectable in developing probiotic products for infants. It is well-known that breast milk constitutes of a non-stopping source of staphylococci, streptococci, bifidobacteria and LAB to infants' gut (Martín et al., 2009).

In the present study, the LAB isolate HM1 from human breast milk was found to be similar to L. paracasei. Neamtu et al. (2014) reported that seven LAB isolates obtained from human breast milk were identified as L. paracasei subsp. paracasei according to their ability to ferment 19 different sugars. The identification was also confirmed by MALDI-TOF MS, which is a rapid, accurate, and reliable technique and is generally used to identify bacterial isolates to the genus, species and subspecies levels (Dušková et al., 2012, Chalupová et al., 2014, Abdelnour et al., 2020b). Similar approaches have also been used to identify molds and yeasts (Bizzini et al., 2011). Furthermore, molecular techniques (e.g. 16S rRNA sequence analysis) have also confirmed the identification of the Lactobacillus strains to the species and subspecies levels (Wang et al., 2011, Verma and Mehata, 2016).

Xu et al. (2018) found that probiotic Lactobacillus casei 393 was able to transform the colorless, toxic form of Se, to reddish, non-toxic and elemental form. Eszenyi et al. (2011) have obtained conflicting results because they have used different probiotic species in the production of nano-sized 100–500 nm Se. Generally, to fabricate biological SeNPs by selected strains of lactobacilli, optimum conditions for biosynthesis must be provided. The medium pH influences the transformation of metal SeNPs by changing the form of biomolecules accountable for capping and stabilizing the NPs (Lortie et al., 1992). Temperature of 30°-37 °C is also a limiting factor, because the biomolecules-mediated sodium selenite reduction is active in this range (Singh et al., 2011, Saxena et al., 2016). Previously, it has been mentioned that high temperatures raise the kinetic energy, resulting in maximum NPs production and rapid synthesis rate (Shakibaie et al., 2011).

It was shown that the concentrations of Na2SeO3 between 1.0 and 4.0 mM did not affect the morphology of the final products (Shamsuzzaman et al., 2017); however, the concentration of 3.0 mM Na2SeO3 was considered to be ideal for synthesizing SeNPs by Acinetobacter sp. (Singh et al., 2011). It has been stated that the reduction rate of Se can be enhanced by increasing Se concentrations up to 19.0 mM (Lortie et al., 1992). However, the reduction rate may be reduced due to the toxicity of Se. Other researchers also reported that the red color intensity increases with time as the solutions were initially greyish-yellow and turned light red after 5 h of incubation (Shamsuzzaman et al., 2017).

It has been found that the time of reduction may vary from one species to another. For example, the color change has been observed by L. rhamnosus within 12 h, followed by L. acidophilus and L. plantarum after 18 h and 26 h of incubation, respectively (Radhika and Gayathri, 2015). In microbial cultivation, the aeration and dissolved oxygen are affected by the agitation speed (Yan et al., 2005). The development of the dark red color demonstrated the formation of SeNPs (Azizi et al., 2014), which complies with the wavelength of the SPR of bio-SeNPs (Yan et al., 2005, Shakibaie et al., 2011, Saxena et al., 2016).

There are many studies associated with the formation of SeNPs that shows various absorption peaks, indicating the presence of SeNPs. In these studies, the peaks have appeared to be at 290 nm (Hemalatha et al., 2014), and the energetic absorption band has been located at 265 nm (Fesharaki et al., 2010). Moreover, another peak has been observed at 263 nm (Khiralla and El-Deeb, 2015). The UV–visible spectroscopy absorption spectra of SeNPs obtained from a culture broth have presented a distinctive property peak at 590 nm, resembling a large particle size of 183 ± 33 nm (Lin and Wang, 2005).

Previous studies have demonstrated that SeNPs can be synthesized by bacteria (Sasidharan and Balakrishnaraja, 2014); however, the main disadvantage was the production of large-sized SeNPs (Hnain et al., 2013). In the present study, SeNPs size particles ranged between 3 and 50 nm in diameter which was not in agreement with the other study (Hnain et al., 2013), which reported a size range of SeNPs between 100 and 550 nm, with a mean size of 245 nm (Neamtu et al., 2014). Similarly, L. acidophilus and Bifidobacterium sp. produced large SeNPs sizes of 50–500 nm and 400–500 nm, respectively; while K. pneumoniae has produced 200–300 nm SeNPs (Fesharaki et al., 2010). The recorded FTIR analysis suggested that organic molecules such as polyphenols, alkaloids, and terpenoids, as already reported (Kalainila et al., 2014), might surround the NPs. The peptides attached to NPs through carboxyl group residues have been reported (Balaji et al., 2009). Some studies have investigated that proteins can bind to NPs through cysteine or amine residues, indicating that these proteins may act as stabilizing agents (Mandal et al., 2005, El-Saadony et al., 2020a).

The recorded FTIR spectrum for the purified SeNPs powder and synthesized by L. acidophilus with bands at 3430 and 3417 cm−1 was attributed to the O-H stretching mode and the N-H stretch in amine groups, respectively (Shamsuzzaman et al., 2017). Broad peaks at 747, 783, and 791 cm−1 have been in accordance with C-H stretching motion, while a narrow peak at 1645 and 1651 cm−1 have been linked to C-C stretching (Shamsuzzaman et al., 2017). The carboxyl, amine and cysteine residues of peptides bind electrostatically with NPs. Hence, the proteins might coat the metal NPs to prevent the accumulation and stability in suspension (Lin and Wang, 2005). The amide linkages can give well-known signatures in the infrared region of the electromagnetic spectrum. The proteins with free amine groups or cysteine residues can bind to gold NPs (Gole et al., 2001).

The results coming from the current study indicated the presence of protein(s) in the supernatant aligned with previous findings (Raliya and Tarafdar, 2013). Overall, evidence of the existence of proteins in the supernatant is also supported by recent reports (El-Saadony et al., 2020a). Many researchers have stated that proteins can bind to SeNPs, either through free cysteine or amine groups in proteins (Raliya and Tarafdar, 2013, El-Saadony et al., 2020a). These proteins, existing over the SeNPs surface, may act as a capping agent for stabilization. Based on this spectrum fingerprint, it can be inferred that many functional groups are present and involved in the conversion of Se ions to SeNPs. Similar results with characterized SeNPs have previously been reported (Zhang et al., 2019).

Similar findings have also been demonstrated, where the obtained XRD patterns have shown the prominent peaks characteristic of the crystalline SeNPs at 2θ values of 23.5°, 29.7°, 41.4°, 43.7° and 45.4°; thus, corresponding to the crystal planes 100, 101, 110, 102 and 111, respectively (Fresneda et al., 2018). The average crystalline size of biogenic Se nanostructures, in the current study, measured by Scherrer's equation was about 34 nm. In another study by Singh et al. (2014), they have demonstrated a peak at 2θ value of 23.680, 29.788, and 43.9 of SeNPs produced by Bacillus sp., indicating the presence of Se which was reduced from selenite ions (Singh et al., 2014). This can be attributed to the different bioactive groups (e.g. polyphenols, alkaloids, carboxyl groups residues, and terpenoids) attached to the bio-SeNPs surface (Kalainila et al., 2014).

The peaks of oxygen (O), carbon (C), sodium (Na), phosphorus (P), chlorine (Cl), and potassium (K) may surround the NPs (Balaji et al., 2009). In the current study, other elements appeared alongside with SeNPs in EDX chromatogram may be due to the bacterial growth medium components. These results are in agreement with Wadhwani et al. (2017).

The NPs that have zeta potential values of > +30 mV or <  − 30 mV (Ramya et al., 2015), maintained the stability of SeNPs as reported by Meléndrez et al. (2010). Electrostatic repulsion was generated between the NPs and that relied on the charges existing on the surface of NPs. The net negative charges on the surface of NPs inhibited aggregation and maintained stability. The bacterial protein covering the surface of the NPs has caused the negative charges responsible for stability (Dhanjal and Cameotra, 2010).

Here, the obtained LAB had powerful antifungal activities against animal pathogenic fungi especially, Candida and Fusarium species. Although C. albicans is considered the most virulent species of Candida, other species might be more pathogenic in certain animals, depending on the site of infection (Diekema et al., 2012). Cutaneous candidiasis is one of the most common skin diseases affecting dogs (Lewis, 2009). Oral and gastrointestinal mucosal candidiasis is common in birds, especially chickens (Odds, 1988, Maubon et al., 2014). Similar candidiasis have been observed in a number of animals (e.g. dogs and cats) at young ages (Odds, 1988). It has been reported that C. guilliermondii and C. parapsilosis cause miscarriages in horses and cattle, mastitis in dairy cows, calves, cats, dogs, horses, and rodents, as well as inflammation of the endocardial surface and eye inflammation in horses (Brito et al., 2009, Al-Yasiri et al., 2016). Candidiasis can also occur as a secondary bacterial infection. Thus, one should consider a feasible option i.e., biogenic SeNPs, such as those produced by L. paracasei HM1 when the hosts do not respond to antibiotic treatments.

Fusarium spp., produces several mycotoxins, which in high doses can lead to severe mycotoxicoses. Where feed contaminated with these toxic mycotoxins has been administered, human consumption of animals, or their edible products, can cause severe brain damage or death (Pohlman and Chengappa, 2013). Feeding pigs on high levels of the mycotoxin DON leads to abdominal distress, malaise, diarrhea, vomiting, and even death (Pohlman and Chengappa, 2013). In horses, fumonisins can cause ELEM (Pitt, 1994). Combined exposure to low doses of DON, T-2 toxin, and ZEN reduces the number of goblet cells in pigs (Devreese et al., 2013). Administration of ZEN alone at higher doses increases goblet cell activity (Bouhet and Oswald, 2005).

The common antifungal drugs, including clotrimazole, econazole, miconazole, terbinafine, fluconazole, ketoconazole and amphotericin, are extreme irritants and can be lethal (Bossche et al., 2003). It has become necessary to develop new types of active, safe and cost-effective fungicidal materials. Bio-synthesized SeNPs such as those reported by Shahverdi et al. (2010) and SeNPs produced by L. paracasei HM1in the current study could be safely used for that purpose.

The results, obtained in the current study, can be explained as being the succession of three mechanisms: 1) easy adhesion to cells, 2) penetration and consequently 3) damaging the cell structures (Guisbiers et al., 2017). It has been shown that SeNPs exhibit high biological effects simultaneously with low toxicity levels (Meléndrez et al., 2010, Netala et al., 2016). Fluconazole, a potent antifungal drug, has shown vigorous antifungal activity against the tested species, and no inhibition zone in the control discs was recorded (Gudikandula and Maringanti, 2016, Netala et al., 2016, Rachitha et al., 2017).

There were some similarities in the action of L. paracasei-SeNPs on F. oxysporum when compared to the essential oil of Mentha piperita on F. sporotrichioides (Rachitha et al., 2017). It has been reported that the population of F. sporotrichioides was reduced by 90% when the fungal pathogen was treated with M. piperita essential oil at 1000 µg ml−1. The effect of M. piperita essential oil on F. sporotrichioides was attributed to the DNA damage and cell wall disruption, which were the most common causes of cell death. The NPs were able to adhere to the cell wall and membrane due to electrostatic interactions; and therefore, disrupt the cell wall. This results in macromolecules' leakage or allows passage through the cell membrane to damage DNA, ultimately leading to cell death (Dakal et al., 2016, Anyasi et al., 2017).

The antimicrobial activity of SeNPs depends on the way they were synthesized. For instance, the antimicrobial efficacy of bio-SeNPs produced by Bacillus mycoides SelTE01 (Bio Se‐NEMO‐S) against Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa NCTC 12934 at 6–24 h was more efficient than Che-SeNPs generated using ascorbic acid (Piacenza et al., 2017). In another study carried out by Sheiha et al. (2020), the bio-SeNPs (78 and 312 µg ml−1) have shown the same antibacterial activity efficacy against all tested bacteria, while the Che-Se (2500 µg ml−1) has shown moderate antimicrobial activity (Sheiha et al., 2020). The present results were consistent with a former study carried out by Cremonini et al. (2016) who demonstrated that Se produced by B. mycoides and Stenotrophomonas maltophilia exhibited stronger antimicrobial action than Che-SeNPs.

The chemical and physical production of NPs cannot be expanded to large-scale production due to several issues, including the presence of toxic organic solvents, hazardous intermediate compounds, and high-energy consumption. This might compromise the animal health and the environment due to the uncertainty in the composition of the final product. Therefore, the focus on using biological production methods is possibly safer for animal use (Keat et al., 2015, Gudikandula and Maringanti, 2016, El-Saadony et al., 2019). Bio-SeNPs and Se have similar biological activity in terms of antioxidant, antibacterial, and anticancer properties (Liu et al., 2004, Jayaprakash and Marshall, 2011, Turner and Butler, 2014, Wang et al., 2014). The NPs produced better activity against the biological materials, albeit the nanoscale sizes and large surface-to-volume ratio. Nano-Se has lower toxicity compared to other chemical forms of supplemented Se (Lippman et al., 2009, Kojouri et al., 2012). Synthesized SeNPs produced by Bacillus sp. have been used as an antifungal agent against C. albicans, with a MIC of 70 μg ml−1 (Shakibaie et al., 2013).

The current study confirmed that the nanoscale biogenic SeNPs synthesized by L. paracasei HM1 had promising in vitro antifungal activity against the clinical fungal species of Candida and Fusarium. Yet, the mechanism of the antifungal effect against these animal pathogenic fungi is unknown and merits further in vivo studies. This will support the development of this class of antifungal “drug” to treat invasive candidiasis and mycotoxicosis in animals.

5. Conclusion

In this study, we investigated a novel treatment for potentially lethal infections in animals caused by Candida and Fusarium species. Biosynthesis of SeNPs using L. paracasei HM1 can be applicable at the commercial level to reduce the dependence on traditional chemical production methods with harmful impacts on the animal health and environment. The SeNPs synthesized by L. paracasei HM1 showed better antifungal activity against the animal fungal pathogens tested in the current study compared to SeNPs synthesized by chemical methods. Biosynthesis of SeNPs using L. paracasei HM1 provides an eco-friendly and safe alternative with protective effects against the most damaging animal fungal pathogens.

Funding

The project was funded by Khalifa Center for Biotechnology and Genetic Engineering (Grant #: 12R028) to S.AQ.; and Abu Dhabi Research Award (AARE2019) for Research Excellence-Department of Education and Knowledge (ADEK-007; Grant #: 21S105) to K.E.-T.

Author contributions

M.T.E.-S, M.M.N., A.M.S., T.F.T., S.AQ, K.E.-T and A.S. conceived and designed the experiments. M.T.E.-S, M.M.N, A.M.S., T.F.T. and A.S. helped in conducting the experiment and collected literature. S.AQ. and K.E.-T helped in constructing the phylogenetic tree. M.T.E.-S, S.AQ., and K.E.-T. analyzed the data and drafted the manuscript. M.T.E.-S, M.M.N., A.M.S., T.F.T., A.S., A.N., N.Z., A.T., S.AQ., and K.E.-T. wrote and finally edited the manuscript. All the authors read and approved the final version of the manuscript.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Footnotes

Peer review under responsibility of King Saud University.

Contributor Information

Synan F. AbuQamar, Email: sabuqamar@uaeu.ac.ae.

Khaled A. El-Tarabily, Email: ktarabily@uaeu.ac.ae.

References

  1. Abdelnour S.A., El-Saadony M.T., Saghir S.A.M., Abd El-Hack M.E., Al-shargi O.Y.A., Al-Gabri N., Salama A. Mitigating negative impacts of heat stress in growing rabbits via dietary prodigiosin supplementation. Livest Sci. 2020;240:104220. doi: 10.1016/j.livsci.2020.104220. [DOI] [Google Scholar]
  2. Abdelnour S.A., Swelum A.A., Salama A., Al-Ghadi M.Q., Qattan S.Y.A., Abd El-Hack M.E., Khafaga A.F., Alhimaidi A.R., Almutairi B.O., Ammari A.A., El-Saadony M.T. The beneficial impacts of dietary phycocyanin supplementation on growing rabbits under high ambient temperature. Ital. J. Anim. Sci. 2020;19:1046–1056. doi: 10.1080/1828051X.2020.1815598. [DOI] [Google Scholar]
  3. Alagawany M., El-Saadony M.T., Elnesr S.S., Farahat M., Attia G., Madkour M., Reda F.M. Use of lemongrass essential oil as a feed additive in quail's nutrition: its effect on growth, carcass, blood biochemistry, antioxidant and immunological indices, digestive enzymes and intestinal microbiota. Poult. Sci. 2021;100:101172. doi: 10.1016/j.psj.2021.101172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alagawany M., Madkour M., El-Saadony M.T., Reda F.M. Paenibacillus polymyxa (LM31) as a new feed additive: antioxidant and antimicrobial activity and its effects on growth, blood biochemistry, and intestinal bacterial populations of growing Japanese quail. Anim. Feed Sci. Technol. 2021;276:114920. doi: 10.1016/j.anifeedsci.2021.114920. [DOI] [Google Scholar]
  5. Alam H., Khatoon N., Khan M.A., Husain S.A., Saravanan M., Sardar M. Synthesis of selenium nanoparticles using probiotic bacteria Lactobacillus acidophilus and their enhanced antimicrobial activity against resistant bacteria. J. Clust. Sci. 2020;31:1003–1011. doi: 10.1007/s10876-019-01705-6. [DOI] [Google Scholar]
  6. Al-Maqtoofi M., Thornton C.R. Detection of human pathogenic Fusarium species in hospital and communal sink biofilms by using a highly specific monoclonal antibody. Environ. Microbiol. 2016;18:3620–3634. doi: 10.1111/1462-2920.13233. [DOI] [PubMed] [Google Scholar]
  7. Al-Yasiri M.H., Normand A.C., Piarroux R., Ranque S., Mauffrey J.F. Gut yeast communities in Larus michahellis from various breeding colonies. Med. Mycol. 2016;55:436–444. doi: 10.1093/mmy/myw088. [DOI] [PubMed] [Google Scholar]
  8. Antonissen G., Martel A., Pasmans F., Ducatelle R., Verbrugghe E., Vandenbroucke V., Li S., Haesebrouck F., van Immerseel F., Croubels S. The impact of Fusarium mycotoxins on human and animal host susceptibility to infectious diseases. Toxins. 2014;6:430–452. doi: 10.3390/toxins6020430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Anyasi T.A., Jideani A.I.O., Mchau G.R.A. Effects of organic acid pretreatment on microstructure, functional and thermal properties of unripe banana flour. J. Food Meas. Charact. 2017;11:99–110. doi: 10.1007/s11694-016-9376-2. [DOI] [Google Scholar]
  10. Argyri A.A., Zoumpopoulou G., Karatzas K.A., Tsakalidou E., Nychas G.J., Panagou E.Z., Tassou C.C. Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests. Food Microbiol. 2013;33:282–291. doi: 10.1016/j.fm.2012.10.005. [DOI] [PubMed] [Google Scholar]
  11. Ashour E.A., Abd El-Hack M.E., Shafi M.E., Alghamdi W.Y., Taha A.E., Swelum A.A., Tufarelli V., Mulla Z.S., El-Ghareeb W.R.R., El-Saadony M.T. Impacts of green coffee powder supplementation on growth performance, carcass characteristics, blood indices, meat quality and gut microbial load in broilers. Agriculture. 2020;10:457. doi: 10.3390/agriculture10100457. [DOI] [Google Scholar]
  12. Azizi S., Ahmad M.B., Namvar F., Mohamad R. Green biosynthesis and characterization of zinc oxide nanoparticles using brown marine macroalga Sargassum muticum aqueous extract. Mater. Lett. 2014;116:275–277. doi: 10.1016/j.matlet.2013.11.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Baek H., Ahn H.R., Cho Y.S., Oh K.H. Antibacterial effects of Lactococcus lactis HK-9 isolated from feces of a newborn infant. Korean J. Microbiol. 2010;46:127–133. [Google Scholar]
  14. Bajaj M., Schmidt S., Winter J. Formation of Se nanoparticles by Duganella sp. and Agrobacterium sp. isolated from Se-laden soil of North-East Punjab, India. Microb. Cell Fact. 2012;11:64. doi: 10.1186/1475-2859-11-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Balaji D.S., Basavaraja S., Deshpande R., Mahesh D.B., Prabhakar B.K., Venkataraman A. Extracellular biosynthesis of functionalized silver nanoparticles by strains of Cladosporium cladosporioides fungus. Colloids Surf B Biointerfaces. 2009;68:88–92. doi: 10.1016/j.colsurfb.2008.09.022. [DOI] [PubMed] [Google Scholar]
  16. Balouiri M., Sadiki M., Ibnsouda S.K. Methods for in vitro evaluating antimicrobial activity: a review. J. Pharm. Anal. 2016;6:71–79. doi: 10.1016/j.jpha.2015.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bizzini A., Jaton K., Romo D., Bille J., Prod’hom G., Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative to 16S rRNA gene sequencing for identification of difficult-to-identify bacterial strains. J. Clin. Microbiol. 2011;49:693–696. doi: 10.1128/JCM.01463-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Boroumand S., Safari M., Shaabani E., Shirzad M., Faridi-Majidi R. Selenium nanoparticles: synthesis, characterization and study of their cytotoxicity, antioxidant and antibacterial activity. Matter. Res. Express. 2019;6:0850d8. doi: 10.1088/2053-1591/ab2558. [DOI] [Google Scholar]
  19. Bossche H.V., Engelen M., Rochette F. Antifungal agents of use in animal health–chemical, biochemical and pharmacological aspects. J. Vet. Pharmacol. Ther. 2003;26:5–29. doi: 10.1046/j.1365-2885.2003.00456.x. [DOI] [PubMed] [Google Scholar]
  20. Bouhet S., Oswald I.P. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet. Immunol. Immunopathol. 2005;108:199–209. doi: 10.1016/j.vetimm.2005.08.010. [DOI] [PubMed] [Google Scholar]
  21. Bozzola J.J., Russell L.D. Jones and Bartlett; Boston: 1999. Electron Microscopy: Principles and Techniques for Biologists; p. 670. [Google Scholar]
  22. Brito E.H.S., Fontenelle R.O.S., Brilhante R.S.N., Cordeiro R.A., Monteiro A.J., Sidrim J.J.C., Rocha M.F.G. The anatomical distribution and antimicrobial susceptibility of yeast species isolated from healthy dogs. Vet. J. 2009;182:320–326. doi: 10.1016/j.tvjl.2008.07.001. [DOI] [PubMed] [Google Scholar]
  23. Chalupová J., Raus M., Sedlářová M., Šebela M. Identification of fungal microorganisms by MALDI-TOF mass spectrometry. Biotechnol. Adv. 2014;32:230–241. doi: 10.1016/j.biotechadv.2013.11.002. [DOI] [PubMed] [Google Scholar]
  24. Chattopadhyay S., Dash S.K., Ghosh T., Das D., Pramanik P., Roy S. Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug delivery. Cancer Nano. 2013;4:103–116. doi: 10.1007/s12645-013-0042-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cremonini E., Zonaro E., Donini M., Lampis S., Boaretti M., Dusi S., Melotti P., Lleo M.M., Vallini G. Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microb. Biotechnol. 2016;9:758–771. doi: 10.1111/1751-7915.12374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dakal T.C., Kumar A., Majumdar R.S., Yadav V. Mechanism basic of antimicrobial action of silver nanoparticles. Front. Microbiol. 2016;7:1831. doi: 10.3389/fmicb.2016.01831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Devreese M., de Backer P., Croubels S. Overview of the most important mycotoxins for the pig and poultry husbandry. Vlaams Diergeneeskd. Tijdschr. 2013;82:171–180. doi: 10.21825/vdt.v82i4.16694. [DOI] [Google Scholar]
  28. Dhanjal S., Cameotra S. Aerobic biogenesis of selenium nanospheres by Bacillus cereus isolated from coalmine soil. Microb. Cell Fact. 2010;9:52. doi: 10.1186/1475-2859-9-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Diekema D., Arbefeville S., Boyken L., Kroeger J., Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn. Microbiol. Infect. Dis. 2012;73:45–48. doi: 10.1016/j.diagmicrobio.2012.02.001. [DOI] [PubMed] [Google Scholar]
  30. Dušková M., Šedo O., Kšicová K., Zdráhal Z., Karpíšková R. Identification of lactobacilli isolated from food by genotypic methods and MALDI-TOF MS. Int. J. Food Microbiol. 2012;159:107–114. doi: 10.1016/j.ijfoodmicro.2012.07.029. [DOI] [PubMed] [Google Scholar]
  31. Dworecka-Kaszak B., Biegańska M.J., Dąbrowska I. Occurrence of various pathogenic and opportunistic fungi in skin diseases of domestic animals: a retrospective study. BMC Vet. Res. 2020;16:248. doi: 10.1186/s12917-020-02460-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. El-Saadony M.T., El-Hack M.E.A., Taha A.E., Fouda M.M.G., Ajarem J.S., Maodaa S.N., Allam A.A., Elshaer N. Ecofriendly synthesis and insecticidal application of copper nanoparticles against the storage pest Tribolium castaneum. Nanomaterials. 2020;10:587. doi: 10.3390/nano10030587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. El-Saadony M.T., Alkhatib F.M., Alzahrani S.O., Shafi M.E., Abdel-Hamid S.E., Taha T.F., Aboelenin S.M., Soliman M.M., Ahmed N.H. Impact of mycogenic zinc nanoparticles on performance, behavior, immune response, and microbial load in Oreochromis niloticus. Saudi J. Biol. Sci. 2021;28:4592–4604. doi: 10.1016/j.sjbs.2021.04.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. El-Saadony M.T., Desoky E.S.M., Saad A.M., Eid R.S., Selem E., Elrys A.S. Biological silicon nanoparticles improve Phaseolus vulgaris L. yield and minimize its contaminant contents on a heavy metals-contaminated saline soil. J. Environ. Sci. 2021;106:1–14. doi: 10.1016/j.jes.2021.01.012. [DOI] [PubMed] [Google Scholar]
  35. El-Saadony M.T., El-Wafai N.A., El-Fattah H.I.A., Mahgoub S.A. Biosynthesis, optimization and characterization of silver nanoparticles biosynthesized by Bacillus subtilis ssp spizizenii MT5 isolated from heavy metals polluted soil. Zagazig J. Agric. Res. 2018;45:2439–2454. doi: 10.21608/zjar.2018.47889. [DOI] [Google Scholar]
  36. El-Saadony M.T., El-Wafai N.A., El-Fattah H.I.A., Mahgoub S.A. Biosynthesis, optimization and characterization of silver nanoparticles using a soil isolate of Bacillus pseudomycoides MT32 and their antifungal activity against some pathogenic fungi. Adv. Anim. Vet Sci. 2019;7:238–249. doi: 10.17582/journal.aavs/2019/7.4.238.249. [DOI] [Google Scholar]
  37. El-Saadony M.T., Sitohy M.Z., Ramadan M.F., Saad A.M. Green nanotechnology for preserving and enriching yogurt with biologically available iron (II). Innov. Food Sci. Emerg. Technol. 2021;69:102645. doi: 10.1016/j.ifset.2021.102645. [DOI] [Google Scholar]
  38. El-Saadony M.T., Saad A.M., Najjar A.A., Alzahrani S.O., Shafi M.E., Alkhatib F.M., Selem E., Desoky E.-S., Fouda S.E.E., El-Tahan A.M., Hassan M.A.A. The use of biological selenium nanoparticles to suppress Triticum aestivum L. crown and root rot diseases induced by Fusarium species and improve yield under drought and heat stress. Saudi J. Biol. Sci. 2021;28(8):4461–4471. doi: 10.1016/j.sjbs.2021.04.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Eszenyi P., Sztrik A., Babka B., Prokisch J. Elemental, nano-sized (100–500 nm) selenium production by probiotic lactic acid bacteria. Int. J. Biosci. Biochem. Bioinform. 2011;1:148–152. doi: 10.7763/IJBBB.2011.V1.27. [DOI] [Google Scholar]
  40. Felsenstein J. Confidence limits on phylogenies: a justification. Evolution. 1985;39:783–791. doi: 10.2307/2408678. [DOI] [PubMed] [Google Scholar]
  41. Fesharaki P.J., Nazari P., Shakibaie M., Rezaie S., Banoee M., Abdollahi M., Shaverdi R. Biosynthesis of selenium nanoparticles using Klebsiella pneumoniae and their recovery by a simple sterilization process. Braz. J. Microbiol. 2010;41:461–466. doi: 10.1590/S1517-83822010000200028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Finney, D.J., 1971. Probit Analysis. Cambridge University Press, New York. J. Pharm. Sci. 60, 1432–1432. https://doi.org/10.1002/jps.2600600940.
  43. Fisher M.C., Henk D.A., Briggs C.J., Brownstein J.S., Madoff L.C., McCraw S.L., Gurr S.J. Emerging fungal threats to animal, plant and ecosystem health. Nature. 2012;484(7393):186–194. doi: 10.1038/nature10947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Forootanfar H., Zare B., Fasihi-Bam H., Amirpour-Rostami S., Ameri A., Shakibaie M., Nami M.T. Biosynthesis and characterization of selenium nanoparticles produced by terrestrial actinomycete Streptomyces microflavus strain FSHJ31. Res. Rev. J. Microbiol. Biotechnol. 2014;3:47–53. [Google Scholar]
  45. Forough M., Farhadi K. Biological and green synthesis of silver nanoparticles. Turkish J. Eng. Env. Sci. 2010;34:281–287. doi: 10.3906/muh-1005-30. [DOI] [Google Scholar]
  46. Fresneda M.A.R., Martín J.D., Bolívar J.G., Cantos F.M.V., Bosch-Estévez G., Moreno M.F.M., Merroun M.L. Green synthesis and biotransformation of amorphous Se nanospheres to trigonal 1D Se nanostructures: impact on Se mobility within the concept of radioactive waste disposal. Environ. Sci. Nano. 2018;5:2103–2116. [Google Scholar]
  47. Ganachari S.V., Bhat R., Deshpande R., Venkataraman A. Extracellular biosynthesis of silver nanoparticles using fungi Penicillium diversum and their antimicrobial activity studies. BioNanoSci. 2012;2:316–321. doi: 10.1007/s12668-012-0046-5. [DOI] [Google Scholar]
  48. Ghorbani H., Attar H., Safekordi A.A., Sorkhabadi S.M.R. Optimization of silver nanoparticles production by E. coli bacterium (DH5 alpha) and the study of reaction kinetics. Asian J. Chem. 2011;23:5111–5118. [Google Scholar]
  49. Gole A., Dash C., Ramachandran V., Sainkar S.R., Mandale A.B., Rao M., Sastry M. Pepsin-gold colloid conjugates: preparation, characterization, and enzymatic activity. Langmuir. 2001;17:1674–1679. doi: 10.1021/la001164w. [DOI] [Google Scholar]
  50. Gudikandula K., Maringanti S.C. Synthesis of silver nanoparticles by chemical and biological methods and their antimicrobial properties. J. Exp. Nanosci. 2016;11:714–721. [Google Scholar]
  51. Guisbiers G., Lara H.H., Mendoza-Cruz R., Naranjo G., Vincent B.A., Peralta X.G., Nash K.L. Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids. Nanomedicine. 2017;13:1095–1103. doi: 10.1016/j.nano.2016.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Gunti L., Dass R.S., Kalagatur N.K. Phytofabrication of selenium nanoparticles from Emblica officinalis fruit extract and exploring its biopotential applications: antioxidant, antimicrobial, and biocompatibility. Front. Microbiol. 2019;30:931. doi: 10.3389/fmicb.2019.00931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hariharan H., Al-Dhabi N.A., Karuppiah P., Rajaram S.K. Microbial synthesis of selenium nanocomposite using Saccharomyces cerevisiae and its antimicrobial activity. Chalcogenide Lett. 2012;9:509–515. [Google Scholar]
  54. Hartikainen H., Xue T., Piironen V. Selenium as an anti-oxidant and pro-oxidant in ryegrass. Plant Soil. 2000;225:193–200. doi: 10.1023/A:1026512921026. [DOI] [Google Scholar]
  55. Hemalatha, T., Krithiga, G., Kumar, B.S., Sastry, T.P., 2014. Preparation and characterization of hydroxyapatite-coated selenium nanoparticles and their interaction with osteosarcoma (SaOS-2) cells. Acta. Metall. Sin. (Engl. Lett.). 27, 1152-1158. Https://doi.org/10.1007/s40195-014-0153-0.
  56. Hnain A., Brooks J., Lefebvre D.D. The synthesis of elemental selenium particles by Synechococcus leopoliensis. Appl. Microbiol. Biotechnol. 2013;97:10511–10519. doi: 10.1007/s00253-013-5304-0. [DOI] [PubMed] [Google Scholar]
  57. Husen A., Siddiqi K.S. Plants and microbes assisted selenium nanoparticles: characterization and application. J. Nanobiotechnology. 2014;12:28. doi: 10.1186/s12951-014-0028-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Jain P.K., Gupta V.K., Misra A.K., Gaur R., Bajpai V., Issar S. Current status of Fusarium infection in human and animal. Asian. J. Anim. Vet. Adv. 2011;6:201–227. [Google Scholar]
  59. Jayaprakash V., Marshall J.R. Selenium and other antioxidants for chemoprevention of gastrointestinal cancers. Best Pract. Res. Clin. Gastroentrol. 2011;25:507–518. doi: 10.1016/j.bpg.2011.09.006. [DOI] [PubMed] [Google Scholar]
  60. Kalainila P., Subha V., Ravindran R.S.E., Renganathan S. Synthesis and characterization of silver nanoparticle from Erythrina indica. Asian. J. Pharm. Clin. Res. 2014;7:39–43. [Google Scholar]
  61. Keat C.L., Aziz A., Eid A.M., Elmarzugi N.A. Biosynthesis of nanoparticles and silver nanoparticles. Bioresour. Bioprocess. 2015;2:47. doi: 10.1186/s40643-015-0076-2. [DOI] [Google Scholar]
  62. Khiralla G.M., El-Deeb B.A. Antimicrobial and antibiofilm effects of selenium nanoparticles on some foodborne pathogens. LWT-Food Sci. Technol. 2015;63:1001–1007. [Google Scholar]
  63. Kojouri G.A., Jahanabadi S., Shakibaie M., Ahadi A.M., Shahverdi A.R. Effect of selenium supplementation with sodium selenite and selenium nanoparticles on iron homeostasis and transferrin gene expression in sheep: a preliminary study. Res. Vet. Sci. 2012;93:275–278. doi: 10.1016/j.rvsc.2011.07.029. [DOI] [PubMed] [Google Scholar]
  64. Kumar S., Stecher G., Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016;33:1870–1974. doi: 10.1093/molbev/msw054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lewis R.E. Overview of the changing epidemiology of candidemia. Curr. Med. Res. Opin. 2009;25:1732–1740. doi: 10.1185/03007990902990817. [DOI] [PubMed] [Google Scholar]
  66. Lin Z.-H., Wang C.R.C. Evidence on the size-dependent absorption spectral evolution of selenium nanoparticles. Mater. Chem. Phys. 2005;92:591–594. [Google Scholar]
  67. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D., Crawford E.D., Goodman G.E., Claudio J., Winquist E., Cook E.D., Karp D.D., Walther P., Lieber M.M., Kristal A.R., Darke A.K., Arnold K.B., Ganz P.A., Santella R.M., Albanes D., Taylor P.R., Probstfield J.L., Jagpal T.J., Crowley J.J., Meyskens F.L., Baker L.H., Coltman C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial. JAMA. 2009;301:39. doi: 10.1001/jama.2008.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Liu M.Z., Zhang S.Y., Shen Y.H., Zhang M.L. Selenium nanoparticles prepared from reverse micro-emulsion process. Chin. Chem. Lett. 2004;15:1249–1252. [Google Scholar]
  69. Logan, N.A., De Vos, P., 2009. Genus I. Bacillus Cohn 1872, 174AL. In : De Vos, P., Garrity, G.M., Jones, D., Krieg, N.R., Ludwig, W., Rainey, F.A., Schleifer, K.H., Whitman, W.B., Eds., Bergey’s Manual of Systematic Bacteriology, 2nd Edition, Springer, New York, 3, 21-128.
  70. Lortie L., Gould W.D., Rajan S., McCready R.G.L., Cheng K.-J. Reduction of selenate and selenite to elemental selenium by a Pseudomonas stutzeri isolate. Appl. Environ. Microbiol. 1992;58:4042–4044. doi: 10.1128/aem.58.12.4042-4044.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Mandal S., Phadtare S., Sastry M. Interfacing biology with nanoparticles. Curr. Appl. Phys. 2005;5:118–127. [Google Scholar]
  72. Martín R., Jiménez E., Heilig H., Fernández L., Marín M.L., Zoetendal E.G., Rodríguez J.M. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl. Environ. Microbiol. 2009;75:965–969. doi: 10.1128/AEM.02063-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Maubon D., Garnaud C., Calandra T., Sanglard D., Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40:1241–1255. doi: 10.1007/s00134-014-3404-7. [DOI] [PubMed] [Google Scholar]
  74. Meléndrez M.F., Cárdenas G., Arbiol J. Synthesis and characterization of gallium colloidal nanoparticles. J. Colloid. Interface Sci. 2010;346:279–287. doi: 10.1016/j.jcis.2009.11.069. [DOI] [PubMed] [Google Scholar]
  75. Mendez M.A.A., Martinez E.S.M., Arroyo L.O., Portillo G.C., Espindola E.S. Synthesis and characterization of silver nanoparticles: effect on phytopathogen Colletotrichum gloeosporioides. J. Nanopart. Res. 2011;13:2525–2532. doi: 10.1007/s11051-010-0145-6. [DOI] [Google Scholar]
  76. Moghaddam A.B., Moniri M., Azizi S., Rahim R.A., Ariff A.B., Saad W.Z., Namvar F., Navaderi M., Mohamad R. Biosynthesis of ZnO nanoparticles by a new Pichia kudriavzevii yeast strain and evaluation of their antimicrobial and antioxidant activities. Molecules. 2017;22:872. doi: 10.3390/molecules22060872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Nacef M., Chevalier M., Chollet S., Drider D., Flahaut C. MALDI-TOF mass spectrometry for the identification of lactic acid bacteria isolated from a French cheese: the Maroilles. Int. J. Food Microbiol. 2017;247:2–8. doi: 10.1016/j.ijfoodmicro.2016.07.005. [DOI] [PubMed] [Google Scholar]
  78. Nam K.T., Kim D.W., Yoo P.J., Chiang C.Y., Meethong N., Hammond P.T., Chiang Y.M., Belcher A.M. Virus-enabled synthesis and assembly of nanowires for lithium-ion battery electrodes. Science. 2006;312:885–888. doi: 10.1126/science.1122716. [DOI] [PubMed] [Google Scholar]
  79. Neamtu B., Ovidiu T., Neamtu M., Mihaela T., Mirela H., Ionela M. Identification of probiotic strains from human milk in breastfed infants with respiratory infections. Acta Univ. Cibiniensis. Ser. E: Food Technol. 2014;18:73–84. doi: 10.2478/aucft-2014-0016. [DOI] [Google Scholar]
  80. Netala V.R., Kotakadi V.S., Domdi L., Gaddam S.A., Bobbu P., Venkata S.K., Ghosh S.B., Tartte V. Biogenic silver nanoparticles: efficient and effective antifungal agents. Appl. Nanosci. 2016;6:475–484. [Google Scholar]
  81. Odds, F.C., 1988. Candida and Candidosis. a review and bibliography. 2nd ed. Baillière Tindall London, UK. 468pp.
  82. Olivares M., Diaz-Ropero M.P., Martin R., Rodriguez J.M., Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J. Appl. Microbiol. 2006;101:72–79. doi: 10.1111/j.1365-2672.2006.02981.x. [DOI] [PubMed] [Google Scholar]
  83. Piacenza E., Presentato A., Zonaro E., Lemire J.A., Demeter M., Vallini G., Tuner R.J., Lampis S. Antimicrobial activity of biogenically produced spherical Se-nanomaterials embedded in organic material against Pseudomonas aeruginosa and Staphylococcus aureus strains on hydroxyapatite-coated surfaces. Microb. Biotechnol. 2017;10:804–818. doi: 10.1111/1751-7915.12700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Pitt J.I. The current role of Aspergillus and Penicillium in human and animal health. J. Med. Vet. Mycol. 1994;32(s1):17–32. doi: 10.1080/02681219480000701. [DOI] [PubMed] [Google Scholar]
  85. Pohlman, L.M., Chengappa, M.M., 2013. Yeasts—Cryptococcus, Malassezia, and Candida, in: McVey, S., Kennedy, M., Chengappa, M.M (Eds.), Veterinary Microbiology. Wiley-Blackwell, pp. 313–320.
  86. Rachitha P., Krupashree K., Jayashree G.V., Gopalan N., Khanum F. Growth inhibition and morphological alteration of Fusarium sporotrichioides by Mentha piperita essential oil. Pharmacognosy Res. 2017;9:74–79. doi: 10.4103/0974-8490.199771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Radhika S.R.R., Gayathri S. Extracellular biosynthesis of selenium nanoparticles using some species of Lactobacillus. Indian J. Geomarine. Sci. 2015;43:766–775. [Google Scholar]
  88. Raliya R., Tarafdar J.C. ZnO nanoparticle biosynthesis and its effect on phosphorous-mobilizing enzyme secretion and gum contents in Clusterbean (Cyamopsis tetragonoloba L.) Agric. Res. 2013;2:48–57. doi: 10.1007/s40003-012-0049-z. [DOI] [Google Scholar]
  89. Ramya S., Shanmugasundaram T., Balagurunathan R. Biomedical potential of actinobacterially synthesized selenium nanoparticles with special reference to anti-biofilm, anti-oxidant, wound healing, cytotoxic and anti-viral activities. J. Trace Elem. Med. Biol. 2015;32:30–39. doi: 10.1016/j.jtemb.2015.05.005. [DOI] [PubMed] [Google Scholar]
  90. Reda F.M., El-Saadony M.T., Elnesr S.S., Alagawany M., Tufarelli V. Effect of dietary supplementation of biological curcumin nanoparticles on growth and carcass traits, antioxidant status, immunity and caecal microbiota of Japanese quails. Animals. 2020;10:754. doi: 10.3390/ani10050754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Reda F.M., El-Saadony M.T., El-Rayes T.K., Attia A.I., El-Sayed S.A., Ahmed S.Y., Madkour M., Alagawany M. Use of biological nano zinc as a feed additive in quail nutrition: biosynthesis, antimicrobial activity and its effect on growth, feed utilization, blood metabolites and intestinal microbiota. Ital. J. Anim. Sci. 2021;20:324–335. doi: 10.1080/1828051X.2021.1886001. [DOI] [Google Scholar]
  92. Saeed E.E., Sham A., Salmin Z., Abdelmowla Y., Iratni R., El-Tarabily K., AbuQamar S. Streptomyces globosus UAE1, a potential effective biocontrol agent for black scorch disease in date palm plantations. Front. Microbiol. 2017;8:1455. doi: 10.3389/fmicb.2017.01455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987;4:406–425. doi: 10.1093/oxfordjournals.molbev.a040454. [DOI] [PubMed] [Google Scholar]
  94. Sambrook J., Fritsch E.F., Maniatis T. 2nd ed. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY: 1989. Molecular Cloning: A Laboratory Manual; p. 1546. [Google Scholar]
  95. Sasidharan S., Balakrishnaraja R. Comparison studies on the synthesis of selenium nanoparticles by various microorganisms. Int. J. Pure App. Biosci. 2014;2:112–117. [Google Scholar]
  96. Saxena J., Sharma P.K., Sharma M.M., Singh A. Process optimization for green synthesis of silver nanoparticles by Sclerotinia sclerotiorum MTCC 8785 and evaluation of its antibacterial properties. SpringerPlus. 2016;5:861. doi: 10.1186/s40064-016-2558-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Seyedmousavi S., Bosco S.M.G., de Hoog S., Ebel F., Elad D., Gomes R.R., Jacobsen I.D., Jensen H.E., Martel A., Mignon B., Pasmans F., Piecková E., Rodrigues A.M., Singh K., Vicente V.A., Wibbelt G., Wiederhold N.P., Guillot J. Fungal infections in animals: a patchwork of different situations. Med. Mycol. 2018;56:S165–S187. doi: 10.1093/mmy/myx104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Shahverdi A.R., Fakhimi A., Mosavat G., Jafari-Fesharaki P., Rezaie S., Rezayat S.M. Antifungal activity of biogenic selenium nanoparticles. World Appl. Sci. J. 2010;10:918–922. [Google Scholar]
  99. Shakibaie M., Forootanfar H., Golkari Y., Mohammadi-Khorsand T., Shakibaie M.R. Antibiofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J. Trace Elem. Med. Biol. 2011;29:235–241. doi: 10.1016/j.jtemb.2014.07.020. [DOI] [PubMed] [Google Scholar]
  100. Shakibaie M., Shahverdi A.R., Faramarzi M.A., Hassanzadeh G.R., Rahimi H.R., Sabzevari O. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm. Biol. 2013;51:58–63. doi: 10.3109/13880209.2012.710241. [DOI] [PubMed] [Google Scholar]
  101. Shamsuzzaman, Mashrai A., Khanam H., Aljawfi R.N. Biological synthesis of ZnO nanoparticles using C. albicans and studying their catalytic performance in the synthesis of steroidal pyrazolines. Arab. J. Chem. 2017;10:S1530–S1536. doi: 10.1016/j.arabjc.2013.05.004. [DOI] [Google Scholar]
  102. Shar A.H., Lakhan M.N., Wang J., Ahmed M., Alali K.T., Ahmed R., Ali I., Dayo A.Q. Facile synthesis and characterization of selenium nanoparticles by the hydrothermal approach. Dig. J. Nanomater. Biostruct. 2019;14:867–872. [Google Scholar]
  103. Sheiha A.M., Abdelnour S.A., Abd El-Hack M.E., Khafaga A.F., Metwally K.A., Ajarem J.S., Maodaa S.N., Allam A.A., El-Saadony M.T. Effects of dietary biological or chemical-synthesized nano-selenium supplementation on growing rabbits exposed to thermal stress. Animals. 2020;10:430. doi: 10.3390/ani10030430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Singh N., Saha P., Rajkumar K., Abraham J. Biosynthesis of silver and selenium nanoparticles by Bacillus sp. JAPSK2 and evaluation of antimicrobial activity. Der. Pharm. Lett. 2014;6:175–181. [Google Scholar]
  105. Singh R.P., Shukla V.K., Yadav R.S., Sharma P.K., Singh P.K., Pandey A.C. Biological approach of zinc oxide nanoparticles formation and its characterization. Adv. Mater. Lett. 2011;2:313–317. doi: 10.5185/amlett.indias.204. [DOI] [Google Scholar]
  106. Smith T.K., Diaz G., Swamy H., Diaz D. In: The Mycotoxin Blue Book. Diaz D., editor. Nottingham University Press; Nottingham: 2005. Current concepts in mycotoxicoses in swine; pp. 235–248. [Google Scholar]
  107. Srivastava N., Mukhopadhyay M. Biosynthesis and structural characterization of selenium nanoparticles using Gliocladium roseum. J. Clust. Sci. 2015;26:1473–1482. doi: 10.1007/s10876-014-0833-y. [DOI] [Google Scholar]
  108. Srivastava S., Singh V., Kumar V., Verma P.C., Srivastava R., Basu V., Gupta V., Rawat A.K. Identification of regulatory elements in 16S rRNA gene of Acinetobacter species isolated from water sample. Bioinformation. 2008;3:173–176. doi: 10.6026/97320630003173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Tamura K., Nei M., Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11030–11035. doi: 10.1073/pnas.0404206101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Tapiero H., Townsend D.M., Tew K.D. The antioxidant role of selenium and seleno-compounds. Biomed. Pharmacother. 2003;57:134–144. doi: 10.1016/S0753-3322(03)00035-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Turner S.A., Butler G. The Candida pathogenic species complex. Cold Spring Harb. Perspect. Med. 2014;2:1–17. doi: 10.1101/cshperspect.a019778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Verma A., Mehata M.S. Controllable synthesis of silver nanoparticles using neem leaves and their antimicrobial activity. J. Radiat. Res. Appl. Sci. 2016;9:109–115. doi: 10.1016/j.jrras.2015.11.001. [DOI] [Google Scholar]
  113. Wadhwani S.A., Gorain M., Banerjee P., Shedbalkar U.U., Singh R., Kundu G.C., Chopade B.A. Green synthesis of selenium nanoparticles using Acinetobacter sp. sW30: optimization, characterization, and its anticancer activity in breast cancer cells. Int. J. Nanomed. 2017;12:6841–6855. doi: 10.2147/IJN.S139212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Wadhwani S.A., Shedbalkar U.U., Singh R., Chopade B.A. Biogenic selenium nanoparticles: current status and future prospects. Appl. Microbiol. Biotechnol. 2016;100:2555–2566. doi: 10.1007/s00253-016-7300-7. [DOI] [PubMed] [Google Scholar]
  115. Wang H., Zhang J., Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic. Biol. Med. 2007;42:1524–1533. doi: 10.1016/j.freeradbiomed.2007.02.013. [DOI] [PubMed] [Google Scholar]
  116. Wang X., Sun K., Tan Y., Wu S., Zhang J. Efficacy and safety of selenium nanoparticles administered intraperitoneally for the prevention of growth of cancer cells in the peritoneal cavity. Free Radic. Biol. Med. 2014;72:1–10. doi: 10.1016/j.freeradbiomed.2014.04.003. [DOI] [PubMed] [Google Scholar]
  117. Wang Y., Chen C., Ai L., Zhou F., Zhou Z., Wang L., Zhang H., Chen W., Guo B. Complete genome sequence of the probiotic Lactobacillus plantarum ST-III. J. Bacteriol. 2011;193:313–314. doi: 10.1128/JB.01159-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Xu J., Li Y., Yang Z., Li C., Liang H., Wu Z., Pu W. Yeast probiotics shape the gut microbiome and improve the health of early-weaned piglets. Front. Microbiol. 2018;9:2011. doi: 10.3389/fmicb.2018.02011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Yan G., Du G., Li Y., Chen J., Zhong J. Enhancement of microbial transglutaminase production by Streptoverticillium mobaraense: application of a two-stage agitation speed control strategy. Process Biochem. 2005;40:963–968. doi: 10.1016/j.procbio.2004.04.002. [DOI] [Google Scholar]
  120. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther. Clin. Risk Manag. 2014;10:95–105. doi: 10.2147/TCRM.S40160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Zhang H., Zhou H., Bai J., Li Y., Yang J., Ma Q., Qu Y. Biosynthesis of selenium nanoparticles mediated by fungus Mariannaea sp. HJ and their characterization. Colloids Surf. A. Physicochem. Eng. Asp. 2019;571:9–16. doi: 10.1016/j.colsurfa.2019.02.070. [DOI] [Google Scholar]

Articles from Saudi Journal of Biological Sciences are provided here courtesy of Elsevier

RESOURCES